BRCA1 and breast cancer: The aim of our study is to evaluate, in a larger group of patients, the contribution of germline mutations in BRCA1 and BRCA2 to breast cancer among Jordanian patients with selected high-risk profile as per the National Comprehensive Cancer Network (NCCN) guidelines [20].